Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Trending Topics

    business

    Worst not over for Ranbaxy; fundamentals a worry: Religare

    Speaking to CNBC-TV18 on the back of Ranbaxy's rally, Arvind Bothra, Religare Capital Markets. opines that though the USFDA has given a clearance to the pharma major‘s Ohm plant, the situation hasn‘t changed much for the company.

    first published: Oct 11, 2013 04:08 pm

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347